Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT

Perioperative Chemotherapy for Gastro-Esophageal or Gastric Cancer: Anthracyclin Triplets versus FLOT

<i>Background:</i> The FLOT4-AIO trial (2019) showed improved survival with perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) compared to anthracyclin triplets in gastric cancer treatment. It is unclear whether these results extend to real-world scenarios in the N...

Full description

Bibliographic Details
Main Authors: Julie F. M. Geerts, Charlène J. van der Zijden, Pieter C. van der Sluis, Manon C. W. Spaander, Grard A. P. Nieuwenhuijzen, Camiel Rosman, Hanneke W. M. van Laarhoven, Rob H. A. Verhoeven, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Bianca Mostert
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Cancers
Subjects:
esophageal cancer
gastro-esophageal cancer
gastric cancer
neoadjuvant chemotherapy
esophagectomy
Online Access:https://www.mdpi.com/2072-6694/16/7/1291

Internet

https://www.mdpi.com/2072-6694/16/7/1291

Similar Items